We are live on ! Find out more
NNVC icon

NanoViricides

42 hedge funds and large institutions have $1.67M invested in NanoViricides in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

11% more funds holding

Funds holding: 3842 (+4)

0.05% more ownership

Funds ownership: 0.26%0.3% (+0.05%)

37% less capital invested

Capital invested by funds: $2.67M → $1.67M (-$997K)

Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NNVC Hedge Fund Activity: Q2 2018 in Review

42 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2018, worth a combined $1.67M — down 37% from $2.67M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NNVC positions and 1 closed out — a net gain of 4 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Cowen Inc, opening a new position worth an estimated $229K. The largest seller was BlackRock, cutting an estimated $60.7K.

  • 42 institutional investors held NanoViricides (NNVC) as of Q2 2018, up from 38 in Q1 2018.
  • Funds reported $1.67M of NanoViricides stock for Q2 2018, down 37% quarter-over-quarter.
  • 5 funds opened new NanoViricides positions in Q2 2018 and 1 closed out, a net change of +4 holders.
  • The largest NanoViricides buyer in Q2 2018 was Cowen Inc, an estimated $229K added.
  • The largest NanoViricides seller in Q2 2018 was BlackRock, an estimated $60.7K sold.

Based on aggregated 13F filings for Q2 2018.